Literature DB >> 19786930

Primary iris stromal cyst with rapid growth.

Yang Xiao1, Yu-Hong Wang, Gai-Ling Niu, Min Gao.   

Abstract

PURPOSE: To describe the clinical features and the surgical management of primary iris stromal cyst with rapid growth.
METHODS: A 14-year-old Chinese-Mongolian girl was referred to us with a 1-month history of obstructed vision and photophobia. On an examination, a semitransparent cyst with a densely pigmented posterior wall was revealed in the anterior chamber of the left eye. The information regarding the location and extent of the cyst was further analyzed by anterior segment optical coherence tomography and ultrasound biomicroscopy. It arose within the iris stroma, measuring 7.52 x 3.60 mm. Blood vessels on the surface of the lesion were revealed by iris angiography. There was no history of amniocentesis, birth trauma, antecedent ocular injury, or maternal illness during gestation. The diagnosis of primary iris stromal cyst was made. A combination of needle aspiration, piecemeal resection of cyst wall, cryotherapy, and argon laser photocoagulation with overlapped spots was used.
RESULTS: Histopathology of the cyst wall revealed nonkeratinized, multilayered, stratified squamous epithelium with clusters of goblet cells. Complete resolution of the cyst was successfully achieved. The visual acuity improved to 20/25 from counting fingers. At 6 months of follow-up, there was no recurrence.
CONCLUSIONS: Complete eradication and devitalization of any remaining epithelial cells are the key factors for preventing recurrence and diffuse epithelialization of the anterior chamber.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786930     DOI: 10.1097/OPX.0b013e3181bb4243

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  1 in total

1.  Ultrasound biomicroscopic evaluation of anterior segment cysts as a risk factor for ocular hypertension and closure angle glaucoma.

Authors:  Abdurrahim Dusak; Mehmet Baykara; Guven Ozkaya; Cuneyt Erdogan; Hikmet Ozcetin; Ercan Tuncel
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.